Literature DB >> 19762779

Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.

Kotaro Takeda1, Toshihiro Ichiki, Eriko Narabayashi, Keita Inanaga, Ryohei Miyazaki, Toru Hashimoto, Hirohide Matsuura, Jiro Ikeda, Toshio Miyata, Kenji Sunagawa.   

Abstract

OBJECTIVE: Prolyl hydroxylase domain-containing proteins (PHDs) play pivotal roles in oxygen-sensing system through the regulation of alpha-subunit of hypoxia-inducible factor (HIF), a key transcription factor governing a large set of gene expression to adapt hypoxia. Although tissue hypoxia plays an essential role in maintaining inflammation, the role of PHDs in the inflammatory responses has not been clearly determined. Here, we investigated the role of PHDs in lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNF-alpha) induction in macrophages. METHODS AND
RESULTS: Northern blot analysis and ELISA revealed that LPS-induced TNF-alpha upregulation was strongly suppressed by PHD inhibitors, dimethyloxallyl glycine (DMOG), and TM6008 in RAW264.7 macrophages. DMOG suppressed LPS-induced TNF-alpha upregulation in HIF-1alpha-depleted cells and HIF-1alpha overexpression failed to suppress the induction of TNF-alpha. DMOG rather suppressed LPS-induced NF-kappaB transcriptional activity. Downregulation of Phd1 or Phd2 mRNA by RNA interference partially attenuated LPS-induced TNF-alpha induction. DMOG also inhibited LPS-induced TNF-alpha production in peritoneal macrophages as well as human macrophages.
CONCLUSIONS: PHD inhibition by DMOG or RNA interference inhibited LPS-induced TNF-alpha upregulation in macrophages possibly through NF-kappaB inhibition, which is independent of HIF-1alpha accumulation. This study suggests that PHDs are positive regulators of LPS-induced inflammatory process, and therefore inhibition of PHD may be a novel strategy for the treatment of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762779     DOI: 10.1161/ATVBAHA.109.196071

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

1.  Identification of novel potential HIF-prolyl hydroxylase inhibitors by in silico screening.

Authors:  Mahesh Kumar Teli; G K Rajanikant
Journal:  Mol Divers       Date:  2011-11-01       Impact factor: 2.943

2.  Prolyl-4-hydroxylase domain protein 2 controls NF-κB/p65 transactivation and enhances the catabolic effects of inflammatory cytokines on cells of the nucleus pulposus.

Authors:  Jun Li; Wen Yuan; Shuai Jiang; Wei Ye; Hao Yang; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

3.  Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.

Authors:  Monal Patel; Dan Predescu; Cristina Bardita; Jiwang Chen; Niranjan Jeganathan; Melanie Pritchard; Salvatore DiBartolo; Roberto Machado; Sanda Predescu
Journal:  Am J Pathol       Date:  2017-01-06       Impact factor: 4.307

4.  Prolyl hydroxylases positively regulated LPS-induced inflammation in human gingival fibroblasts via TLR4/MyD88-mediated AKT/NF-κB and MAPK pathways.

Authors:  Lingling Shang; Ting Wang; Dongdong Tong; Wenyan Kang; Qianyu Liang; Shaohua Ge
Journal:  Cell Prolif       Date:  2018-08-09       Impact factor: 6.831

5.  Immunologic Consequences of Hypoxia during Critical Illness.

Authors:  Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

6.  The PHD1 oxygen sensor in health and disease.

Authors:  Kilian B Kennel; Julius Burmeister; Martin Schneider; Cormac T Taylor
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

7.  Inhibition of prolyl hydroxylase domain-containing protein: a novel therapy for cardiovascular diseases?

Authors:  Takehiko Takayanagi; Satoru Eguchi
Journal:  Hypertension       Date:  2011-08-08       Impact factor: 10.190

8.  Inhibition of Endothelial PHD2 Suppresses Post-Ischemic Kidney Inflammation through Hypoxia-Inducible Factor-1.

Authors:  Ganeshkumar Rajendran; Michael P Schonfeld; Ratnakar Tiwari; Shengping Huang; Rafael Torosyan; Timothy Fields; Jihwan Park; Katalin Susztak; Pinelopi P Kapitsinou
Journal:  J Am Soc Nephrol       Date:  2020-01-29       Impact factor: 10.121

9.  The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and IL-10 production by B1 cells.

Authors:  Emily Hams; Sean P Saunders; Eoin P Cummins; Aisling O'Connor; Murtaza T Tambuwala; William M Gallagher; Annette Byrne; Antonio Campos-Torres; Paul M Moynagh; Christian Jobin; Cormac T Taylor; Padraic G Fallon
Journal:  Shock       Date:  2011-09       Impact factor: 3.454

Review 10.  Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.

Authors:  Sophie Van Welden; Andrew C Selfridge; Pieter Hindryckx
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-08-30       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.